Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
65,881,982
-
Total 13F shares
-
14,558,956
-
Share change
-
-151,884
-
Total reported value
-
$22,523,713
-
Put/Call ratio
-
0%
-
Price per share
-
$1.55
-
Number of holders
-
46
-
Value change
-
-$221,659
-
Number of buys
-
18
-
Number of sells
-
21
Institutional Holders of Cytosorbents Corp - Common Stock, par value $0.001 per share (CTSO) as of Q4 2022
As of 31 Dec 2022,
Cytosorbents Corp - Common Stock, par value $0.001 per share (CTSO) was held by
46 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,558,956 shares.
The largest 10 holders included
Skylands Capital, LLC, AVENIR CORP, VANGUARD GROUP INC, Granahan Investment Management, LLC, Neuberger Berman Group LLC, Sargent Investment Group, LLC, BlackRock Inc., CM Management, LLC, GEODE CAPITAL MANAGEMENT, LLC, and Redmile Group, LLC.
This page lists
46
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.